Invivyd (IVVD) EBITDA (2021 - 2025)

Invivyd (IVVD) has 5 years of EBITDA data on file, last reported at -$11.1 million in Q4 2025.

• For the quarter ending Q4 2025, EBITDA rose 39.93% year-over-year to -$11.1 million; the trailing twelve-month figure through Dec 2025 stood at -$52.5 million (up 69.09% YoY), and the FY2025 full-year result was -$52.5 million, up 69.09% from the prior year.
• EBITDA for Q4 2025 stood at -$11.1 million, down from -$10.5 million in the prior quarter.
• Across five years, EBITDA topped out at -$10.5 million in Q3 2025 and bottomed at -$100.7 million in Q1 2022.
• The 5-year median for EBITDA is -$44.8 million (2021), against an average of -$44.5 million.
• The widest annual swing landed in 2022, when EBITDA plunged 160.1%; it then surged 82.76% in 2025.
• A 5-year view of EBITDA shows it stood at -$83.1 million in 2021, then soared by 45.95% to -$44.9 million in 2022, then plunged by 64.09% to -$73.7 million in 2023, then soared by 74.98% to -$18.4 million in 2024, then soared by 39.93% to -$11.1 million in 2025.
• The last three EBITDA figures came in at -$11.1 million (Q4 2025), -$10.5 million (Q3 2025), and -$14.7 million (Q2 2025), per Business Quant data.

Peer Comparison